| 1 |
Perner A, Cecconi M, Cronhjort M, et al. Expert statement for the management of hypovolemia in sepsis [J]. Intensive Care Med, 2018, 44(6): 791-798.
|
| 2 |
Prescott HC, Angus DC. Postsepsis morbidity [J]. JAMA, 2018, 319(1): 91.
|
| 3 |
Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority - a WHO resolution [J]. N Engl J Med, 2017, 377(5): 414-417.
|
| 4 |
Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000 [J]. N Engl J Med, 2003, 348(16): 1546-1554.
|
| 5 |
WHO. Shining a spotlight on maternal and neonatal sepsis: World Sepsis Day 2017 [Z/OL]. (2017-9-12)[2018-10-20].
URL
|
| 6 |
Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis [J]. Lancet Glob Health, 2014, 2(6): e323-333.
|
| 7 |
Kumar A, Roberts D, Wood KE, et al . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock [J]. Crit Care Med, 2006, 34(6): 1589-1596.
|
| 8 |
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
|
| 9 |
Shankar-Hari M, Phillips GS, Levy ML, et al. Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 775-787.
|
| 10 |
Bonet M, Nogueira Pileggi V, Rijken MJ, et al. Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation [J]. Reprod Health, 2017, 14(1): 67.
|
| 11 |
Bowyer L, Robinson HL, Barrett H, et al. SOMANZ guidelines for the investigation and management sepsis in pregnancy [J]. Aust N Z J Obstet Gynaecol, 2017, 57(5): 540-551.
|
| 12 |
Chebbo A,Tan S,Kassis C,et al. Maternal sepsis and septic shock [J]. Crit Care Clin, 2016, 32(1): 119-135.
|
| 13 |
樊尚荣. 产科重症感染的多学科防治 [J/CD]. 中华产科急救电子杂志, 2017, 6(3): 129-132.
|
| 14 |
张惜阴. 实用妇产科学 [M]. 北京: 人民卫生出版社, 2003: 467.
|
| 15 |
Acosta CD, Bhattacharya S, Tuffnell D, et al. Severe maternal sepsis: identifying actions to address morbidity and mortality. In Knight M,Acosta C,Brocklehurst P,et al eds. Beyond maternal death: improving the quality of maternal care through national studies of 'near-miss'maternal morbidity [J]. Programme Grants Appl Res, 2016, 4(9): 41-64.
|
| 16 |
刘平, 樊尚荣. 妊娠期和产褥期脓毒症 [J]. 中华产科急救电子杂志, 2013, 2(4): 253-256.
|
| 17 |
陈磊, 刘朝晖. 绒毛膜羊膜炎的致病菌及药敏分析 [J]. 中国妇产科临床杂志, 2016, 17(2): 140-143.
|
| 18 |
Pollard K. The fundamental skills: reducing maternal morbidity and mortality [J]. Pract Midwife, 2017, 20(3): 23-25.
|
| 19 |
Albright CM, Has P, Rouse DJ, et al. Internal validation of the sepsis in obstetrics score to identify risk of morbidity from sepsis in pregnancy [J]. Obstet Gynecol, 2017, 130(4): 747-755.
|
| 20 |
Rajkumari N, Mathur P, Sharma S, et al. Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study [J]. J Lab Physicians, 2013, 5(2): 100-108.
|
| 21 |
Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis [J]. Lancet Infect Dis, 2013, 13(5): 426-635.
|
| 22 |
Shirakawa K, Furusako S, Endo S, et al. New diagnostic marker for Sepsis: soluble CD14 subtype [J]. J Crit Care, 2004, 8(Suppl 1): P19l.
|
| 23 |
Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome [J]. J Infect Chemother, 2011, 17(6): 764-769.
|
| 24 |
Liu B, Chen YX, Yin Q, et al. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department [J]. Crit Care, 2013, 17(5): R244.
|
| 25 |
Shozushima T, Takahashi G, Matsumoto N, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome [J]. J Infect Chemother, 2011, 17(6): 764-769.
|
| 26 |
Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST) [J]. Clin Chim Acta, 2011, 412(23-24): 2157-2161.
|
| 27 |
Shallcross LJ, Mentzer A, Rahman S, et al. Cohort study protocol: Bioresource in Adult Infectious Diseases (BioAID) [J]. Wellcome Open Res, 2018, 3: 97.
|
| 28 |
Fleuren LM, Klausch TLT, Zwager CL, et al. Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy [J]. Intensive Care Med, 2020, 46(3): 383-400.
|
| 29 |
Neonatal Sepsis Initiative Working Group. Electronic address: bonetm@who.int.The Global Maternal and Neonatal Sepsis Initiative: a call for collaboration and action by 2030 [J]. Lancet Glob Health, 2017, 5: e390-391.
|